The board of directors of Baxter International Inc (NYSE:BAX) declared a quarterly dividend of USD0.22 per share of the company's common stock, it disclosed on Tuesday.
This cash dividend will be paid on 1 October 2019 to shareholders of record as of 30 August 2019.
Annually, the dividend rate is equivalent t0 USD0.88 per share of common stock, according to the company.
With products, technologies and therapies available in 100 countries, Baxter's portfolio consist of critical care, nutrition, renal, hospital as well as surgical products.
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement